Selective inhibitory effect of epigallocatechin-3-gallate on migration of vascular smooth muscle cells

Molecules

Volumn 15, Issue 11, 2010, Pages 8488-8500

  Han, Dong Wook ^a   Lee, Mi Hee ^b   Kwon, Byeong Ju ^b   Kim, Hye Lee ^b   Hyon, Suong Hyu ^c   Park, Jong Chul ^b  

^a Pusan National University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Eigallocatechin 3 gallate; Migration; Proliferation; Vascular endothelial cells; Vascular smooth muscle cells

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE;

ANIMAL; ARTICLE; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; RAT; SMOOTH MUSCLE FIBER; SPRAGUE DAWLEY RAT;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CATECHIN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; IMMUNOHISTOCHEMISTRY; MALE; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 78649469700     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15118488     Document Type: Article

References (36)

1. Tsai, S.; Butler, J.; Rafii, S.; Liu, B.; Kent, K.C. The role of progenitor cells in the development of intimal hyperplasia. J. Vasc. Surg. 2009, 49, 502-510.
2. Gibbons, G.H.; Dzau, V.J. The emerging concept of vascular remodeling. N. Engl. J. Med. 1994, 330, 1431-1438.
3. Ross, R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993, 362, 801-809.
4. Lindner, V.; Reidy, M.A. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 1991, 88, 3739-3743.
5. Ferns, G.A.; Raines, E.W.; Sprugel, K.H.; Motani, A.S.; Reidy, M.A.; Ross, R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991, 253, 1129-1132.
6. Chang, W.; Lim, S.; Song, H.; Song, B.W.; Kim, H.J.; Cha, M.J.; Sung, J.M.; Kim, T.W.; Hwang, K.C. Cordycepin inhibits vascular smooth muscle cell proliferation. Eur. J. Pharmacol. 2008, 597, 64-69.
7. Rosenthal, D.; Stevens, S.L.; Skillern, C.S.; Wellons, E.D.; Robinson, K.; Matsuura, J.H.; Gannon, B.J. Topical application of β-radiation to reduce intimal hyperplasia after carotid artery balloon injury in rabbit. A possible application for brachytherapy in vascular surgery. Cardiovasc. Radiat. Med. 2002, 3, 16-19.
8. O'Connor, D.M.; O'Brien, T. Nitric oxide synthase gene therapy: Progress and prospects. Expert Opin. Biol. Ther. 2009, 9, 867-878.
9. Gershlick, A.H. Treating atherosclerosis: Local drug delivery from laboratory studies to clinical trials. Atherosclerosis 2002, 160, 259-271.
10. Na, H.-K.; Surh, Y.-J. Intracellular signaling network as a prime chemopreventive target of (-)- epigallocatechin gallate. Mol. Nutr. Food Res. 2006, 50, 152-159.
11. Bar-Sela, G.; Epelbaum, R.; Schaffer, M. Curcumin as an anti-cancer agent: Review of the gap between basic and clinical applications. Curr. Med. Chem. 2010, 17, 190-197.
12. Li, Y.; Kong, D.; Wang, Z.; Sarkar, F.H. Regulation of microRNAs by natural agents: An emerging field in chemoprevention and chemotherapy research. Pharm. Res. 2010, 27, 1027-1041.
13. Stangl, V.; Lorenz, M.; Stangl, K. The role of tea and tea flavonoids in cardiovascular health. Mol. Nutr. Food Res. 2006, 50, 218-228.
14. Stangl, V.; Dreger, H.; Stangl, K.; Lorenz, M. Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc. Res. 2007, 73, 348-358.
15. Jochmann, N.; Baumann, G.; Stangl, V. Green tea and cardiovascular disease: From molecular targets towards human health. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11, 758-765.
16. Frei, B.; Higdon, J.V. Antioxidant activity of tea polyphenols in vivo: Evidence from animal studies. J. Nutr. 2003, 133, 3275S-3284S.
17. Rice-Evans, C.A.; Miller, N.J.; Paganga, G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 1996, 20, 933-956.
18. Han, D.-W.; Lee, J.J.; Jung, D.Y.; Park, J.-C.; Hyon, S.-H. Development of epigallocatechin gallate-eluting polymeric stent and its physicochemical, biomechanical and biological evaluations. Biomed. Mater. 2009, 4, 044104.
19. Han, D.-W.; Hyon, S.-H.; Park, J.-C. Protection and preservation of vascular cells and tissues by green tea polyphenols. In Polyphenols and Health: New and Recent Advances, 1st ed.; Vassallo, N., Ed.; Nova Science Publishers, Inc.: New York, NY, USA, 2008; pp. 87-111.
20. Rah, D.K.; Han, D.-W.; Baek, H.S.; Hyon, S.-H.; Park, J.-C. Prevention of reactive oxygen species-induced oxidative stress in human microvascular endothelial cells by green tea polyphenol. Toxicol. Lett. 2005, 155, 269-275.
21. Ohga, N.; Hida, K.; Hida, Y.; Muraki, C.; Tsuchiya, K.; Matsuda, K.; Ohiro, Y.; Totsuka, Y.; Shindoh, M. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumorassociated endothelial cells and endothelial progenitor cells. Cancer Sci. 2009, 100, 1963-1970.
22. Ross, R. Atherosclerosis is an inflammatory disease. Am. Heart J. 1999, 138, S419-S420.
23. Chyu, K.Y.; Babbidge, S.M.; Zhao, X.; Dandillaya, R.; Rietveld, A.G.; Yano, J.; Dimayuga, P.; Cercek, B.; Shah, P.K. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 2004, 109, 2448-2453. (Pubitemid 38679566)
24. Hofmann, C.S.; Sonenshein, G.E. Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53. FASEB J. 2003, 17, 702-704.
25. Han, D.-W.; Lim, H.R.; Baek, H.S.; Lee, M.H.; Lee, S.J.; Hyon, S.-H.; Park, J.-C. Inhibitory effects of epigallocatechin-3-O-gallate on serum-stimulated rat aortic smooth muscle cells via nuclear factor-κB down-modulation. Biochem. Biophys. Res. Commun. 2006, 345, 148-155.
26. Won, S.M.; Park, Y.H.; Kim, H.J.; Park, K.M.; Lee, W.J. Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway. Exp. Mol. Med. 2006, 38, 525-534.
27. Alvarez, E.; Campos-Toimil, M.; Justiniano-Basaran, H.; Lugnier, C.; Orallo F. Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aorta. Br. J. Pharmacol. 2006, 147, 269-280.
28. Weber, A.A.; Neuhaus, T.; Skach, R.A.; Hescheler, J.; Ahn, H.Y.; Schror, K.; Ko, Y.; Sachinidis, A. Mechanisms of the inhibitory effects of epigallocatechin-3 gallate on platelet-derived growth factor-BB-induced cell signaling and mitogenesis. FASEB J. 2004, 18, 128-130.
29. Galis, Z.S.; Khatri, J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ. Res. 2002, 90, 251-262.
30. Huang, Y.; Mironova, M.; Lopes-Virella, M.F. Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 2640-2647.
31. Sukhova, G.K.; Schonbeck, U.; Rabkin, E.; Schoen, F.J.; Poole, A.R.; Billinghurst, R.C.; Libby, P. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation, 1999, 99, 2503-2509.
32. Cho, H.H.; Han, D.-W.; Matsumura, K.; Tsutsumi, S.; Hyon, S.-H. The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(L-lactide-co-ε- caprolactone) as stent-coating materials. Biomaterials 2008, 29, 884-893.
33. Han, D.-W.; Jung, D.Y.; Park, J.-C.; Cho, H.H.; Hyon, S.-H.; Han, D.K. Underlying mechanism for suppression of vascular smooth muscle cells by green tea polyphenol EGCG released from biodegradable polymers for stent application. J. Biomed. Mater. Res. A 2010, 95, 424-433.
34. Lim, H.R.; Baek, H.S.; Lee, M.H.; Woo, Y.I.; Han, D.-W.; Han, M.H.; Baik, H.K.; Choi, W.S.; Park, K.D.; Chung, K.-H.; Park, J.-C. Surface modification for enhancing behaviors of vascular endothelial cells onto polyurethane films by microwave-induced argon plasma. Surf. Coat. Technol. 2008, 202, 5768-5772.
35. Park, J.-C.; Park, B.J.; Suh, H.; Park, B.Y.; Rah, D.K. Comparative study on motility of the cultured fetal and neonatal dermal fibroblasts in extracellular matrix. Yonsei Med. J. 2001, 42, 587-594.
36. Woo, Y.I.; Park, B.J.; Kim, H.L.; Lee, M.H.; Kim, J.; Yang, Y.I.; Kim, J.K.; Tsubaki, K.; Han, D.-W.; Park, J.-C. The biological activities of (1,3)-(1,6)-β-D-glucan and porous electrospun PLGA membranes containing beta-glucan in human dermal fibroblasts and adipose tissue-derived stem cells. Biomed. Mater. 2010, 5, 044109.